Comparison of mortality in ESRD patients on convective and diffusive extracorporeal treatments

Kidney International

Volumn 55, Issue 1, 1999, Pages 286-293

  Locatelli, Francesco ^a   Marcelli, Daniele ^b   Conte, Ferruccio ^b   Limido, Aurelio ^b   Malberti, Fabio ^b   Spotti, Donatella ^b  

^a A MANZONI HOSPITAL   (Italy)

^b NONE

Author keywords

Carpal tunnel syndrome; Dialysis related amyloidosis; Hemodiafiltration; Hemodialysis; Renal replacement therapy

Indexed keywords

ADULT; AGED; AMYLOIDOSIS; ARTICLE; CARPAL TUNNEL SYNDROME; COMORBIDITY; DIABETES MELLITUS; FEMALE; HEMODIALYSIS; HEMOFILTRATION; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SURGICAL RISK; TREATMENT OUTCOME;

EID: 0032947298     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00236.x     Document Type: Article

References (33)

1. Vanholder R, De Smet R, Vogeleere P, Hsu C, Ringoir S: The uraemic syndrome, in Replacement of Renal Function by Dialysis, edited by Jacobs C, Kjellstrand C, Koch K, Winchester J, Dordrecht, Kluwer Academic, 1996, pp 1-34
2. Locatelli F, Mastrangelo F, Redaelli B, Ronco C, Marcelli D, La Greca G, Orlandini G, Italian Cooperative Dialysis Study Group: Effect of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters. Kidney Jnt 50:1293-1302, 1996
3. Henderson LW, Livoti LG, Ford CA, Kelly AB, Lysaght MJ: Clinical experience with intermittent hemofiltration. Trans Am Soc Artif Organs 19:119-123, 1973
4. Leber HW, Wizeman V, Goubeaud G, Rawer P, Schuetterle G: Simultaneous hemofiltration/hemodialysis: An effective alternative to hemofiltration and conventional hemodialysis in the treatment of uremic patients. Clin Nephrol 9:115-121, 1978
5. Locatelli F, Marcelli D, Conte F, Limido A, Lonati F, Malberti F, Spotti D: 1983-1992: Report on regular dialysis and transplantation in Lombardy. Am J Kidney Dis 25:196-205, 1995
6. Cox DR: Regression models and life tables (with discussion). J R Stat Soc 34:197-220, 1972
7. Crowley J, Hu M: Covariance analysis of heart transplant data. J Am Stat Assoc 72:27-36, 1977
8. Collett D: Modelling Survival Data in Medical Research. London, Chapman & Hall, 1994
9. SPSS Advanced Statistics, Version 7.5. Chicago, SPSS Inc., 1997
10. Marcelli D, Stannard D, Conte F, Held PJ, Locatelli F, Port FK: ESRD patient mortality with adjustment for comorbid conditions in Lombardy (Italy) versus the United States. Kidney Int 50:1013-1018, 1996
11. Locatelli F, Marcelli D, Conte F: Dialysis patient outcomes in Europe vs the USA: Why do Europeans live longer? Nephrol Dial Transplant 12:1816-1819, 1997
12. Van Ypersele De Strihou C, Jadoul M, Malghem J, Maldague B, Jamart J, Working Party on Dialysis Amyloidosis: Effect of dialysis membrane and patients age on signs of dialysis related amyloidosis. Kidney Int 39:1012-1019, 1991
13. 2-microglobulin and advanced glycation end product in the development of dialysis related-amyloidosis. Kidney Int 51:1514-1519, 1997
14. 2-microglobulin levels in chronic hemodialysis patients. J Am Soc Nephrol 7:472-478, 1996
15. Gejyo F, Arakawa M: Dialysis amyloidosis: Current disease concepts and new perspectives for its treatment. Contrib Nephrol 78:47-60, 1990
16. 1-antichymotrypsin in dialysis-related amyloidosis. Kidney Int 52(Suppl 62):S75-S78, 1997
17. 2-microglobulin associated amyloidosis: A vanishing complication of long-term hemodialysis? Kidney Int 52:1077-1083, 1977
18. Charra B, Calemard E, Laurent G: Chronic renal failure treatment duration and mode: Their relevance to the late dialysis periarticular syndrome. Blood Purif 6: 117-124, 1988
19. 2-microglobulin amyloidosis in haemodialysis: A prospective post-mortem study. Kidney Int 52:1928-1932, 1997
20. Chanard J, Bindi P, Lavaud S, Toupance O, Maheut H, Lacour F: Carpal tunnel syndrome and type of dialysis membrane. BMJ 298:867-868, 1989
21. Brunner FP, Brynger H, Ehrich JHH, Fassbinder W, Geerlings W, Rizzoni G, Selwood NH, Tufveson G, Wing AJ: Case control study on dialysis arthropathy. The influence of two different dialysis membranes: Data from the EDTA Registry. Nephrol Dial Transplant 5:432-436, 1990
22. Kessler M, Netter P, Azoulay E, Mayeux D, Pere P, Gaucher A: Dialysis-associated arthropathy. A multicentre survey of 171 patients receiving haemodialysis for over 10 years: The Cooperative Group on dialysis-associated arthropathy. Br J Rheumatol 31:157-162, 1992
23. Bonomini V, Coli L, Feliciangeli G, Nanni Costa A, Scolari MP: Long-term comparative evaluation of synthetic and cellulosic membranes in dialysis. Int J Artif Organs 17:392-398, 1994
24. Koda Y, Nishi S, Miyazaki S, Haginoshita S, Sakurabayashi T, Suzuki M, Sakai S, Yausa Y, Hirasawa Y, Nishi T: Switch from conventional to high-flux membrane reduces the risk of carpal tunnel syndrome and mortality of hemodialysis patients. Kidney Int 52:1096-1101, 1997
25. Kuchle C, Lang SM, Held E, Schiffl H: High-flux hemodialysis postpones clinical manifestation of dialysis-related amyloidosis. Am J Nephrol 16:484-488, 1996
26. Kabanda A, Jadoul M, Pochet JM, Lauwerys R, Van Ypersele De Strihou C, Bernard A: Determinants of the serum concentrations of low molecular weight proteins in patients on maintenance hemodialysis. Kidney Int 45:1689-1696, 1994
27. Lehnert H, Jacob C, Marzoll I, Schmidt-Gayk H, Stein G, Ritz E, Diabetes Amyloid Study Group: Prevalence of dialysis related amyloidosis in diabetic patients. Nephrol Dial Transplant 11:2004-2007, 1996
28. Hornberger JC, Chernew M, Petersen J, Garber AM: A multivariate analysis of mortality and hospital admissions with high flux dialysis. J Am Soc Nephrol 3:1227-1237, 1992
29. Woods HF: Evidence for a biocompatibility-independent effect of high-flux dialysis on improved patient survival. (abstract) Nephrology 3(Suppl 1):415, 1997
30. 2-microglobulin removal by different hemodialysis membranes: A six year followup. Contrib Nephrol 112:156-163, 1995
31. Hakim RM, Held PJ, Stannard DC, Wolfe RA, Port FK, Daugirdas JT, Agodoa L: Effect of the dialysis membrane on mortality of chronic hemodialysis patients. Kidney Int 50:566-570, 1996
32. Eknoyan G, Levey AS, Beck GJ, Agodoa LY, Daugirdas JT, Kusek JW, Levin NW, Schulman G: The Haemodialysis (HEMO) Study: Rationale for selection of interventions. Semin Dial 9:24-33, 1996
33. Locatelli F, Manzoni C: Biocompatibility in haemodialysis: Fact and fiction. Curr Opin Nephrol Hypertens 6:528-532, 1997